Back to search

Aristotle University Of Thessaloniki (AUTH)

Development and validation of high-performance liquid chromatographic methods for the determination of 1,4-benzodiazepines in bio-fluids

Abstract

dc:description

Analytical chemistry; detection (qualitative) and quantitation (quantitative), of substances is not a new branch of science. There has been very rapid development of new methods of analysis, since the third or fourth decade of the century. In modern society the analytical chemists have a very important role to play. These developments have come largely through necessity in connection with rapid expansion of the industrial economy, as well as with extensive growth of research programmes in many varied fields. The nation’s health is safe-guarded by continual checking (analysis) of foods, drugs, cosmetics, water supplies, waste disposal methods etc. In hospitals chemical analysis is widely used to assist in the diagnosis of illness and in monitoring the condition of patients. Medical and biological research programmes depend on analysis of various kinds in broadening our knowledge of vital processes and in the development of therapeutic agents to combat disease. However, the recent increase in reports of drug-facilitated crimes (sexual assault, robbery) has caused alarm in the general public. The drugs involved can be pharmaceuticals, such as benzodiazepines, hypnotics, sedatives or anaesthetics, serotonergic drugs, tricyclic antidepressants, drugs of abuse, such as cannabis, ecstasy. Benzodiazepines have hypnotic, tranquillizing and anticonvulsant properties and are frequently encountered in clinical and forensic science casework. Benzodiazepines are among the most frequently prescribed drugs for the treatment of anxiety, sleep disturbance and status epileptics. On the other hand tricyclic antidepressants are the most popular class of drugs in the treatment of depression. For the medical treatment of depression and neurosis, the concomitant administration of benzodiazepines and tricyclic antidepressants is widely practised. Quantification of drugs in the bio-samples; blood, plasma, serum, urine, saliva etc. procedure is important prerequisites for competent toxicological judgment and consultation in clinical and forensic toxicology. Oral fluid (saliva) is used today as a readily available alternative to blood for some applications in therapeutic drug monitoring and increasingly for testing drugs of abuse in many environments, including law enforcement, workplace or roadside drug testing. For the bio-pharmacological, clinical, toxicological or forensic consequences the availability of rapid, high sensitive and selective analytical methods for their determination in biological fluids are essential. To perform successful examinations, analyst must obtain as soon as possible the corresponding biological specimens and subsequent analysis using sophisticated analytical techniques (gas or liquid chromatography) with time and cost effective methods. Though gas chromatography–mass spectrometry (GC–MS) is the most widely used reference method but liquid chromatography coupled with UV/DAD is the first choice in consideration of their availability. The dissertation comprises description on structure and properties of examined drugs (1,4-benzodiazepines and tricyclic antidepressants), basic concepts on HPLC and SPE, elaborate review on the biological sample preparation and different analytical methods adopted for their determination. Experimental section details the chemicals, instrumentations used throughout the experiments, experimental procedures. Brief discussion on validation parameters is presented in method validation chapter. As the goal of dissertation three HPLC methods have been developed, validated and successfully applied to pharmaceuticals and bio-fluids. Separation of drugs in presence of colchicine as internal standard was performed on Kromasil (C8-5 μm, 250 × 4 mm, 100) analytical column using a mobile phase consisting CH3OH:0.05M,CH3COONH4:CH3CN under gradient program at ambient temperature. The analytes were extracted from biological samples by Nexus Varian SPE cartridges and detected by DAD set at 240 nm. First: HPLC method has been developed for the simultaneous separation and quantification of six 1,4-benzodiazepines (alprazolam, bromazepam, clonazepam, diazepam, flunitrazepam, lorazepam) in pharmaceutical and biological matrices (human plasma, urine) after solid-phase extraction (SPE). The drug/internal standard peak area ratios were linked in quadratic relationships to its concentrations giving linearity range of 0.20-15.00 ng μL-1 for each BDZs except BRZ that of which is 0.1-18.0 ng μL-1 with coefficient of determination greater than 0.993. Recoveries and RSD were between 92-111% and 0.1-3.1%, respectively from pharmaceutical/biological samples. The limit of detection (LOD) and limit of quantitation (LOQ) values were 0.03-0.17 ng μL-1 and 0.2-0.5 ng μL-1, respectively. The method was also applied to a real urine sample from a patient under treatment with alprazolam. Second: HPLC method has been developed for the determination of six 1,4-benzodiazepines: bromazepam, clonazepam, diazepam, flunitrazepam, lorazepam, alprazolam, along with two metabolites: α-hydroxyalprazolam, α-hydroxytriazolam in human plasma, urine and saliva samples after SPE. Calibration curves were linear from 0.2-20 ng µL-1 in standard for all except alprazolam. For alprazolam in standard and for all analytes in biological fluids linear range was 0.3-20.0 ng µL-1 with coefficient of determination (r2) better than 0.997. The Within-day assay (n = 6) RSD were 0.2-1.3%, 0.3-1.9%, 0.4-1.6%, 0.4-1.7% and the between-day assay (n = 6) RSD were 0.2-1.7%, 0.7-2.5%, 0.5-2.1%, 0.4-3.0% for standard, plasma, urine and saliva, respectively. The percentage mean recoveries for all analytes were from 96.3-108.6, 96.0-108.2, 94.3-107.1, 97.0-107.0 in within-day analysis and from 96.8-107.7, 94.6-107.6, 93.2-105.8, 96.0-108.6 in between-day analysis for standard, plasma, urine and saliva, respectively. LOD and LOQ were in 0.02-0.5 and 0.07-1.6 ng µL-1, respectively. Third: HPLC assay has been developed for the simultaneous determination of six 1,4-benzodiazepines as above combination with three tricyclic antidepressants, amitriptyline, clomipramine, doxepin, in pharmaceuticals and human plasma, urine, saliva after SPE. Calibration curves were linear for both 1,4-benzodiazepines and tricyclic antidepressants up to 20 ng µL-1 with coefficient of determination (r2) 0.999. LOD and LOQ were in 0.1-1.2 ng µL-1 and 0.3-3.9 ng µL-1, respectively. The mean recoveries of all analytes in all matrices were 85-108.7% (n = 6) for within-day and 86-109.9% (n=6) for between-day assays having good precision (RSD< 4%). The sample preparation was very simple and methods were rapid, simple, selective and sensitive enough and reproducible. The methods described here would be useful tool in medicinal chemistry, suitable for use both in clinical analysis as well as for quality control of pharmaceutical formulations. A solid-phase extraction procedure was optimized when a careful specific sequential elution was performed to elute 1,4-benzodiazepines from SPE using a mixture of methanol-acetonitrile (1:1) followed by the elution of tricyclic antidepressants with methanol. Both benzodiazepines (six) and tricyclic antidepressants (four) were simultaneously separated and detected using the same chromatographic conditions developed in third method. Both diazepam and imipramin, those overlapped each other under this chromatographic conditions, were successfully determined with losing their selectivity. Method was applied successfully in human fluids, and anlytes were determined with recoveries of 86-107% for plasma, urine and saliva having good precision (RSD) values less than 10%. The procedure is simple, fast and reliable with good specificity and sensitivity, will be suitable for use in a clinical setting, where there is a concomitant use of benzodiazepines and tricyclic antidepressants, and for routine analysis in quality control for two component tablet formulations. The influence of long-term storage on the stability of six 1,4-benzodiazepines; alprazolam, bromazepam, clonazepam, diazepam, flunitrazepam and lorazepam in spiked plasma, urine and saliva samples was investigated at defined time intervals. Spiked samples (0.5, 2.0 ng µL-1) were stored at -20°C, and analysed at selected times during 180 days for both plasma and urine, and 120 days for saliva. Quantification was carried out using the method described in first method after SPE. At -20°C, at the end of the observation period the measured decrease was around 40% for flunitrazepam and clonazepam, and around 20% for remaining four benzodiazepines of the original levels. At end of study period for low concentrations (0.5 ng µL-1) all benzodiazepines were though detectable but a clear pattern of breakdown could not be established. Result of stability study through freeze-thaw cycle during seven successive days for spiked samples stored at -20°C revealed that analytes were completely stable up to five cycles in plasma, urine, and up to three cycles in saliva. Moreover, stability study of all analytes over a period of one year revealed that standard solution in methanol stored at 4oC can be used without any remarkable degradation.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2009

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Uddin, Mohammad Nasir

Subjects

dc:subject × 18

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/27803

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Uddin, Mohammad Nasir. Development and validation of high-performance liquid chromatographic methods for the determination of 1,4-benzodiazepines in bio-fluids. Aristotle University Of Thessaloniki (AUTH), 2009. http://hdl.handle.net/10442/hedi/27803